COMMUNIQUÉS West-GlobeNewswire

IMUNON Announces Leadership Change
12/03/2024
Executive Chairman to lead day-to-day operations, active search underway for CEO successor. Timing of upcoming milestones for key programs remains unchanged. LAWRENCEVILLE, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- [...]
Quipt Home Medical Announces Participation in the 36th Annual Roth Investor Conference on March 17-19, 2024
12/03/2024
CINCINNATI, March 12, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “ Company ”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced [...]
Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
12/03/2024
LOWELL, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate [...]
LE QUÉBEC MANQUE UNE OCCASION DE TAXER LES BOISSONS SUCRÉES
12/03/2024
MONTRÉAL, 12 mars 2024 (GLOBE NEWSWIRE) -- Le Collectif Vital a consulté avec attention le budget 2024-2025 dévoilé aujourd’hui par le ministre des Finances, M. Éric Girard. Force est de constater que la taxation des [...]
Ardelyx, Inc. Reports Employment Inducement Grants
12/03/2024
WALTHAM, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet [...]
Shineco Regains Compliance with Nasdaq Minimum Bid Price Requirement
12/03/2024
BEIJING, March 12, 2024 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that on March 11, 2024, the [...]
Gavriel Dardashti Uncovers Power of Full Moon on Quantum Electrodynamics
12/03/2024
Ibogaine By David Dardashti Explores Quantum Electrodynamics as Influencer of Electromagnetic Waves During Full Moon Miami, March 12, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti has announced their [...]
Cronos Group Inc. to Speak at the 36th Annual Roth Conference
12/03/2024
TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President [...]
Litigation Update - Safety Shot Authorized to Serve Notice of Motion for Default Judgment Upon Capybara Research and Igor Appelboom by Public Disclosure and Press Release
12/03/2024
JUPITER, FL, March 12, 2024 (GLOBE NEWSWIRE) -- On December 5, 2023, Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”) announced that it filed a federal lawsuit in the United States District Court for [...]
Maravai LifeSciences Announces March 2024 Investor Conference Schedule
12/03/2024
SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the [...]
Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024
12/03/2024
MINNEAPOLIS, March 12, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela”), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical [...]
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance
12/03/2024
MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 Guidance ROCKVILLE, MD, March 12, 2024 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company [...]
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
12/03/2024
SOUTH SAN FRANCISCO, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet [...]
SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023
12/03/2024
• Increased Product Sales to $131 Million in 2023 • Grew Pre-tax Operating Income to $84 Million in 2023 • Declared Today a Special Cash Dividend of $0.60 per Share • Corporate Update Conference Call Today at 4:30 PM ET [...]
RadNet Announces Closing of Public Offering of Common Stock
12/03/2024
LOS ANGELES, March 12, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, announced today the closing of [...]
Venus Concept Launches “NEXThetics” Program
12/03/2024
New Venus AI Event Series Focused on Enhancing Customer Education and Training TORONTO, March 12, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. ("Venus Concept" or the "Company") (NASDAQ: VERO), a global medical aesthetic [...]
Crinetics Announces Positive Topline Results from Phase 2 Trial of Paltusotine for the Treatment of Carcinoid Syndrome
12/03/2024
Paltusotine Treatment Demonstrated Rapid and Sustained Reductions in Frequency and Severity of Flushing Episodes and Bowel Movements Paltusotine was Generally Well-Tolerated and Showed an Overall PK Profile Consistent [...]
Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
12/03/2024
- Phase 2b ODYSSEY Wet AMD Trial Remains on Track with Topline Data Expected in Q3 2024 - - Partner Programs Continue to Report Positive Clinical Data Utilizing SCS Microinjector ® - - Strengthened Capital Position from [...]
Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry
12/03/2024
Rates of Post Thrombotic Syndrome at two years were excellent and significantly lower than rates reported in historical Deep Vein Thrombosis trials IRVINE, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc [...]

Pages